During the past decade, Hjørring Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hjørring Hospital" #1 sponsor was "Advanz Pharma" with 4 trials, followed by "Vendsyssel Hospital" with 2 trials sponsored, "Anders Perner" with 1 trials sponsored, "Henrik Wiggers" with 1 trials sponsored and "Morten H. Bestle" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hjørring Hospital" #1 collaborator was "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 3 trials as a collaborator, "University of Copenhagen" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator, "Rigshospitalet, Denmark" with 2 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hjørring Hospital" are "Atrial Fibrillation" (3 trials), "Septic Shock" (2 trials), "Antibiotic Resistance, Bacterial" (1 trials), "Atrial Flutter" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Hjørring Hospital" in a lesser frequency.

Most popular intervention types in "Hjørring Hospital" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vernakalant Injection 20 mg/mL" (2 trials), "6% Hydroxyethyl starch 130/0.4" (1 trials), "Alendronate" (1 trials), "Amiodarone Injection:" (1 trials) and "Calcium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hjørring Hospital" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hjørring Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hjørring Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hjørring Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".